Vitamin D and Subsequent Systolic Hypertension Among Women American Journal of Hypertension, 02/22/11 |
Griffin FC et al. – Consistent with previous animal
and human studies, the authors found a single–time measure of vitamin D among young adult women was associated with systolic hypertension 14 years later. These prospective results
suggest the need for further study of the role vitamin D insufficiency in early adulthood as a risk factor in subsequent hypertension among women. |
Vitamin D and the Prevention of Hypertension and Cardiovascular Diseases: A Review
of the Current Evidence American Journal of Hypertension, 03/07/11 |
Geleijnse JM – Epidemiological data suggest that optimal vitamin D status is important for cardiovascular disease (CVD) prevention, but results from different studies are conflicting and confounding cannot be ruled out. Randomized?controlled trials of vitamin D supplementation and BP have yielded inconsistent results, and trials that addressed the effect of vitamin D on CVDs are lacking. |
Osteoporosis in men Best Practice & Research Clinical Endocrinology & Metabolism, 03/21/11 |
Gielen E et al. – Male osteoporosis is an increasingly important public health problem: from age 50 onward, one in three osteoporotic fractures occurs in men and fracture–related morbidity and mortality are even higher than in women. In 50% of osteoporotic men, an underlying cause can be identified (secondary osteoporosis). |
Use of Fibrates in the United States and Canada JAMA, 03/23/11 |
Jackevicius CA et al. - During the past decade, prescriptions for fibrates (particularly fenofibrate) increased in the United States, while prescriptions for fibrates in
Canada remained stable. Methods
|
Your Article SummaryInitial hypertension treatment: one combination fits mostJournal of the American Society of Hypertension, 03/22/11 |
Brook RD et al. - Authors outline a novel algorithm of starting initial therapy with a single tablet containing amlodipine + benazepril in most patients with hypertension
regardless of stage or comorbidities. This streamlined approach is likely to yield an overall positive risk/benefit ratio. Methods
|
No comments:
Post a Comment